Magnolol attenuates macrophage pyroptosis triggered by Streptococcus equi subsp. zooepidemicus

Yuxuan Liu1, Meijun Lu1, Qian Sun1

  • 1School of Life Science and Engineering, Foshan University, Foshan, China.

PubMed

Insights

The herbal extract magnolol shows promise as an alternative treatment for Streptococcus equi subsp. zooepidemicus (SEZ) infections. Magnolol reduced inflammation and protected mice against SEZ by suppressing pyroptosis in macrophages.

Area of Science:

  • Microbiology
  • Immunology
  • Pharmacology

Background:

  • Streptococcus equi subsp. zooepidemicus (SEZ) is a zoonotic pathogen causing severe infections.
  • Antibiotic resistance necessitates alternative treatments for SEZ infections.

Purpose of the Study:

  • To investigate the protective effects of magnolol against SEZ infection.
  • To elucidate the mechanism by which magnolol mitigates SEZ-induced inflammation.

Main Methods:

  • Mice were infected with SEZ and treated with magnolol.
  • Macrophage pyroptosis and inflammatory markers were analyzed.
  • Bacterial burden and survival rates were assessed.

Main Results:

  • Magnolol significantly increased survival rates and reduced bacterial load in infected mice.
  • Magnolol downregulated pyroptosis-related proteins in SEZ-infected macrophages.
  • Magnolol inhibited pyroptosis and subsequent inflammation in macrophages.

Conclusions:

  • Magnolol demonstrates therapeutic potential against SEZ infection.
  • Magnolol's anti-inflammatory and anti-pyroptotic properties offer a novel treatment strategy for SEZ.
  • Magnolol provides a promising alternative to antibiotics for treating SEZ infections.